Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | AMGN | VRTX | REGN | GSK |
| Company | Ascendis Pharma ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 129.26 | 306.42 | 451.90 | 984.04 | 45.42 |
| High | 130.30 | 307.50 | 457.66 | 993.27 | 45.45 |
| Low | 126.79 | 303.90 | 449.42 | 983.16 | 45.03 |
| Last | 130.24 | 306.70 | 455.99 | 992.12 | 45.18 |
| Change | +0.80 | +0.20 | +5.19 | +11.55 | +0.03 |
| % Change | +0.62% | +0.07% | +1.15% | +1.18% | +0.07% |
| Volume | 92,054 | 488,387 | 346,183 | 82,058 | 931,662 |
| 20-Day Average Volume | 512,654 | 2,770,392 | 1,126,292 | 415,818 | 3,861,117 |
| Previous Close | 129.44 | 306.50 | 450.80 | 980.57 | 45.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 131.37 | 303.31 | 424.46 | 961.75 | 44.27 |
| 20-Day Raw Stochastic | 47.93% | 71.59% | 96.55% | 94.88% | 80.36% |
| 20-Day Relative Strength | 43.69% | 58.71% | 73.83% | 61.54% | 61.58% |
| Weighted Alpha | +39.06 | +37.92 | +40.15 | +36.37 | +34.88 |
| Today's Opinion | 8% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 8% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 24% Buy | 72% Sell | 8% Buy | 8% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.12% since 05/17/24 | -1.63% since 05/17/24 | +2.29% since 05/17/24 | +0.99% since 05/17/24 | +0.13% since 05/17/24 |
| Low | 120.12 on 05/20/24 | 303.90 on 05/24/24 | 437.46 on 05/21/24 | 975.73 on 05/23/24 | 44.40 on 05/20/24 |
| High | 133.09 on 05/22/24 | 316.67 on 05/21/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | -9.39% since 04/24/24 | +12.59% since 04/24/24 | +13.63% since 04/24/24 | +9.43% since 04/24/24 | +10.23% since 04/24/24 |
| Low | 116.63 on 05/14/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 40.81 on 04/25/24 |
| High | 143.99 on 05/02/24 | 322.60 on 05/03/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -18.61% since 02/23/24 | +6.29% since 02/23/24 | +5.88% since 02/23/24 | +1.10% since 02/23/24 | +6.68% since 02/23/24 |
| Low | 116.63 on 05/14/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 161.00 on 02/26/24 | 322.60 on 05/03/24 | 457.66 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +40.65% since 11/24/23 | +15.79% since 11/24/23 | +28.99% since 11/24/23 | +24.26% since 11/24/23 | +25.77% since 11/24/23 |
| Low | 90.13 on 11/28/23 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.35 on 11/29/23 |
| High | 161.00 on 02/26/24 | 329.72 on 02/05/24 | 457.66 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,536,514 | 164,417,328 | 116,330,288 | 108,045,080 | 93,570,672 |
| Shares Outstanding, K | 58,224 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 288,670,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -521,070,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 104,110,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -142,260,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.54 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 05/02/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 29.72 | 26.51 | 11.33 |